News for Australian Clinical Labs Limited (ACL.AX)

Revenue: $696 million.EBIT: $62.6 million.EBIT Margin: 9% for the full year, 11% in the second half.Non-COVID Revenue: $646.7 million, up 5.4% on FY23.Underlyi

The ASX200 closed down more than 2% at 7,943 points. Despite hitting a fresh all-time record yesterday, the bourse retreated down below the 8,000 level.

Pathology chains have lost ground while major miners made gains following the federal budget, with the ASX200 overall finishing 0.4 per cent higher.

Mar 19, 2023 / 11:30PM GMTMichael Alscher - Australian Clinical Labs Limited - Non-executive Chair Good morning, everyone, and welcome to the presentation on Au

In this article, we will be taking a look at the 20 biggest health care companies in Australia, 2024.

Australian shares traded lower on Tuesday, as the losses in heavyweight banking stocks overshadowed the gains in miners, while traders awaited the fourth-quarter domestic growth data due later this...

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.75% to 7,476.60.

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.09% to 7,414.80.

The S&P/ASX 200 (INDEXASX: XJO) to gained 0.9 per cent on Friday.  The All Ordinaries (INDEXASX: XAO) added 0.8 per cent with every sector barring utilities and real estate finishing higher.

The Santa rally appears to be coming early this year, with the local bourse rising for a sixth straight day in its second-best week of the year. The S&P/ASX200 index on Friday finished up 64.8 points, or 0.88 per cent, to 7,442.7, while the broader All Ordinaries rose 62.5 points, or 0.82 per cent, to […]

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.051% to 7068.80.

Tribeca Investment Partners believes sees attractive opportunities in some of the more beaten down sectors of small caps.

Resmed CDI (ASX:RMD) shares and the Monash IVF Group Ltd (ASX:MVF) share price look very tempting at these prices, writes Seneca's Luke Laretive.

Healius (ASX:HLS) has confirmed the receipt of an off-market takeover bid from Australian Clinical Labs (ASX:ACL).

A mixed finish on Wall Street points to a flat start to…

Welcome to the October 2022 Investment Update for the Switzer Dividend Growth Fund . Click here to download the report. Performance Summary ... | November 9, 2022

There's a myth that you must buy blue chips to get dividends. These 10 ASX small caps can earn you those divvies.

Greta's resources pick, some ridiculously unloved biotechs, and a how to get in for the long haul on some of the world's biggest companies.

Australian shares looked set to open lower as investors weigh declines in…